IL-1 Antibody definition

IL-1 Antibody means, [*], any [*] and [*] and [*] and [*] For clarity, [*]
Sample 1Sample 2Sample 3
IL-1 Antibody means the Novartis antibody known as ACZ885 as at the Effective Date.
Sample 1Sample 2Sample 3
IL-1 Antibody means [************************************] and which shall be subject to the IL-1 Antibody Opt-In Rights.
Sample 1Sample 2

Examples of IL-1 Antibody in a sentence

  • Unless otherwise agreed upon by the Parties (and as permitted by applicable Law or applicable industry codes), Novartis shall be responsible for such posting for any IL-1 Antibody or IL-1 Products.

  • Each Party agrees that each clinical study and each nonclinical study with respect to any IL-1 Antibody or IL-1 Product that is required to be posted pursuant to applicable Law or applicable industry codes, including the PhRMA Code or the equivalent industry code of practice, on xxxxxxxxxxxxxx.xxx or any other similar registry shall be so posted.

  • Upon expiration of the Term of this Agreement with respect to the IL-1 Antibody Product in a country as contemplated by Section 19.2(a), all licenses and rights with respect to the IL-1 Antibody Product in such country granted to Regeneron hereunder shall automatically terminate and revert to Novartis and in such event, the provisions of Part B of SCHEDULE 19 shall apply with respect to the IL-1 Antibody Product in such country as if the IL-1 Antibody Product is a "Terminated Product".

  • Accordingly, the Parties confirm that, pursuant to the IL-1 Antibody Termination Agreement, the Parties agree that, with effect from the Effective Date, the CLO Agreement is terminated and of no further force or effect (other than as set forth in the IL-1 Antibody Termination Agreement and other than with respect to definitions of terms defined in the CLO Agreement which are expressly referenced in this Agreement).

  • Subject to the terms and conditions of this Agreement and any license within the Novartis Patent Rights, Novartis and its Affiliates hereby grant to Regeneron and its Affiliates the right and license under the Novartis Intellectual Property to Co-Develop, Co-Commercialize and Co-Market the IL-1 Antibody Product throughout the IL-1 Antibody Territory for the Term of this Agreement with respect to the IL-1 Antibody Product.

  • In carrying out Development activities hereunder with respect to IL-1 Products, neither Party shall use the services of any Person involved in the Development of any Trap-1 Product, IL-1 Antibody Product (following the End of Phase II Development) or Trap-2 Product (following the End of Phase II Development) which is not an IL-1 Product subject to the Co-Development and/or Co-Commercialization rights pursuant to this Agreement, if the use of such services would violate applicable Law.

  • Regeneron hereby waives any and all rights it may have with respect to the IL-1 Antibody, and any IL-1 Antibody Product, pursuant to the CLO Agreement or any other agreement (other than this Agreement) between any of the Parties existing as of the Effective Date relating to the IL-1 Antibody or any IL-1 Antibody Product.

  • If Regeneron has properly exercised the IL-1 Antibody Opt-In Rights, then with respect to Annual Net Sales of any IL-1 Antibody Product in Europe and in accordance with the terms and conditions set forth in SCHEDULE 3 hereto, Novartis shall pay to Regeneron the applicable royalty as set forth in SCHEDULE 3.

  • Novartis shall also promptly notify Regeneron of, and promptly provide to Regeneron, all material new data relating to the IL-1 Antibody Product that comes into Novartis' possession during such period, whether or not such data is specifically requested by Regeneron.

  • With respect to the IL-1 Antibody, all rights not specifically granted herein to Regeneron are expressly reserved to Novartis.

Related to IL-1 Antibody

  • Antibody means a molecule comprising or containing one or more immunoglobulin variable domains or any fragments, derivatives, variants or modifications thereof that bind to the same antigen.

  • Licensed Compound means [***].

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).

  • Licensed Compounds means: (a) Research Program Active Compounds; (b) Novartis Active Compounds; (c) salts, hydrates, solvates, esters, metabolites, intermediates, stereoisomers and polymorphs of Research Program Active Compounds or Novartis Active Compounds; and (d) prodrugs of Research Program Active Compounds or Novartis Active Compounds (any of the foregoing, a “Licensed Compound”).

  • Lead Compound means any compound of lead other than galena which, when treated in the manner described below, yields to an aqueous solution of hydrochloric acid a quantity soluble lead compound exceeding, when calculated as lead monoxide, five percent of the dry weight of the portion taken analysis.

  • Development Candidate means a Compound that meets the Development Candidate Criteria for the initiation of a Development Program for the treatment of CF, and which is the subject of a notice from Vertex to CFFT that Vertex intends to commence formal pre-clinical development of the Compound in the Field pursuant to the provisions of Section 3.1 hereof.

  • Product Candidate means any pharmaceutical product developed, manufactured and/or tested by or on behalf of the Company that has not received a Regulatory Authorization for commercial distribution other than in connection with pre-clinical or clinical trials.

  • Collaboration Target means the Initial Collaboration Targets set forth on Exhibit F and any Additional Target or Substitute Target that is selected in accordance with Section 3.3 of this Agreement.

  • Antigen means a substance recognized by the body as being foreign; it results in the production of specific antibodies directed against it.

  • Diagnostic Product means any test or assay for diagnosing or detecting a disease, disorder, medical condition, or symptom.

  • Back-Up Compound means, with reference to any particular Development Candidate or Drug Product Candidate, a Compound which (a) has the same principal mode of action (i.e., Potentiator or Corrector) as that Development Candidate or Drug Product Candidate; and (b) was among the group of Compounds, identified by VERTEX as potential additional lead molecules having the same principal mode of action, from which the Development Candidate was selected.

  • Collaboration Product means a pharmaceutical product containing or comprising Compound in any dosage form alone, or in combination with, one or more other pharmaceutically active ingredients, and any and all Improvements thereto.

  • Compounds means any or all of the following chemicals, as the context requires:

  • Biological Samples means any physical samples obtained from Study Participants in accordance with the Protocol for the purposes of the Study.

  • Compound means the taking of two or more ingredients and fabricating them into a single

  • Reference biological product means the single biological product licensed pursuant to 42 U.S.C.

  • Therapeutic Product means a health product categorised as a therapeutic product in the First Schedule to the Act;

  • Biological product means a virus, therapeutic serum, toxin, antitoxin, vaccine, blood, blood component or derivative, allergenic product, protein other than a chemically synthesized polypeptide, or analogous product, or arsphenamine or any derivative of arsphenamine or any other trivalent organic arsenic compound, applicable to the prevention, treatment, or cure of a disease or condition of human beings.

  • Nicotine product means a product that contains nicotine and is not any of the following:

  • Hemp product means the same as that term is defined in § 3.2-4112.

  • complex product means a product which is composed of multiple components which can be replaced permitting disassembly and re-assembly of the product.

  • Vaccine means a specially prepared antigen which, upon administration to a person, will result in immunity and, specifically for the purposes of this rule, shall mean influenza and pneumococcal vaccines.

  • Licensed Product means a product or part of a product in the Licensed Field of Use: (A) the making, using, importing or selling of which, absent this license, infringes, induces infringement, or contributes to infringement of a Licensed Patent; or (B) which is made with, uses or incorporates any Technology.

  • Biomarker means a parameter or characteristic in a patient or Patient Sample, the measurement of which is useful (a) for purposes of selecting appropriate therapies or patient populations or monitoring disease susceptibility, severity or state, or monitoring therapies for such patient and/or (b) for predicting the outcome of a particular treatment of such patient.

  • Drug Product means a specific drug in dosage form from a known source of manufacture, whether

  • Biosimilar Product means, with respect to a Licensed Product and on a country-by-country basis, a product that [***].